Endevica Bio, located in Northbrook, IL, is a pioneering biotechnology company focused on developing a groundbreaking therapeutic for cachexia. With their lead molecule, they aim to establish a new standard of care for the millions of patients affected by cachexia annually, offering hope for improved health outcomes and increased survival rates across various acute and chronic diseases.
Endevica Bio's innovative approach to reversing cachexia holds the potential to transform the lives of patients by addressing the underlying causes of this debilitating condition. Through their cutting-edge research and development efforts, they strive to make a significant impact on the field of medicine and provide much-needed relief to individuals suffering from cachexia.
Generated from the website